entity

NDD

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about NDD: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

2Connections
0Hypotheses
1Analyses
0Outgoing
2Incoming

Wiki Pages (19)

Knowledge base pages for this entity

CBS/PSP Clinical Trials Guide

therapeutic · 4969 words

creatine-supplementation-neurodegeneration

therapeutic · 3971 words

Stress Granule Dysfunction Hypothesis in Parkinson's Disease

hypothesis · 3115 words

CBS Natural History Study (NCT06691234)

clinical · 2866 words

Taisho Pharmaceutical

company · 2715 words

Outgoing (0)

TargetRelationTypeStr
No outgoing edges

Incoming (2)

SourceRelationTypeStr
MICROGLIAL_SENESCENCEcontributes_tophenotype0.64
NEUROINFLAMMATIONassociated_withphenotype0.56

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (1)

Scientific analyses that reference this entity

Autophagy-lysosome pathway convergence across neurodegenerative diseases

neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.665

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found